During obesity, chemerin appears to exacerbate local and systemic inflammation, a key contributor to insulin resistance and adipose tissue expansion; it has been shown to recruit circulating dendritic cells to visceral adipose tissue. Here, RARRES2 is linked to obesity disorder.